SeaStar Medical Holding Corporation Warrant financials
$0.0154−6.10%
Close Sep 25, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $615.0K | $495.0K | $420.0K | $183.0K | $338.0K | $293.0K | $67.0K | $68.0K | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $561.0K | $449.0K | $408.0K | $169.0K | $311.0K | $293.0K | $67.0K | $68.0K | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | 91.2% | 90.7% | 97.1% | 92.3% | 92.0% | 100.0% | 100.0% | 100.0% | — | — | — | — |
| Operating income | -$3.8M | -$3.6M | -$3.0M | -$3.6M | -$1.8M | -$3.8M | -$4.8M | -$4.5M | -$4.7M | -$4.0M | -$2.9M | -$2.9M |
| Net income | -$3.7M | -$3.5M | -$2.9M | -$3.5M | -$2.0M | -$3.8M | -$4.4M | -$4.5M | -$3.2M | -$12.7M | -$9.5M | -$7.2M |
| Net margin | −606.5% | −711.3% | −691.4% | −1897.3% | −592.3% | −1287.4% | −6595.5% | −6585.3% | — | — | — | — |
| Diluted EPS | $-0.91 | $-0.90 | — | $-1.30 | $-1.77 | $-4.38 | $-8.75 | $-11.00 | $-10.30 | $-47.30 | $-34.17 | $-90.20 |
| EBITDA | -$3.8M | -$3.6M | -$3.0M | -$3.6M | -$1.8M | -$3.8M | -$4.8M | -$4.5M | -$4.7M | -$4.0M | -$2.9M | -$2.9M |
| Operating cash flow | -$3.0M | -$2.8M | -$4.1M | -$3.8M | -$3.0M | -$2.7M | -$4.7M | -$5.0M | -$2.8M | -$3.5M | -$4.5M | -$1.3M |
| Free cash flow | -$3.0M | -$2.8M | -$4.1M | -$3.8M | -$3.0M | -$2.7M | -$4.7M | -$5.0M | -$2.8M | -$3.5M | -$4.5M | -$1.3M |
| Diluted shares | 4.1M | 3.9M | — | 2.6M | 1.1M | 0.9M | 0.5M | 0.4M | 0.3M | 0.3M | 0.3M | 0.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.0M | $9.3M | $12.0M | $13.8M | $6.3M | $5.3M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $134.0K | $331.0K | $525.0K | $0.00 | $0.00 | $363.0K |
| Total assets | $8.6M | $11.3M | $14.2M | $15.5M | $8.4M | $7.6M |
| Total liabilities | $4.4M | $3.9M | $3.7M | $4.1M | $5.0M | $7.0M |
| Shareholders' equity | $4.3M | $7.3M | $10.4M | $11.5M | $3.3M | $565.0K |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology